Artificial Intelligence (AI) in Radiation Dosing Market by Type of Modalities (Computed Tomography, CT Scan, MRI, Mammography, X-ray, Ultrasound and Others); By End User (Hospitals, Diagnostic Center, Medical Institutions, Other Medical Groups); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Artificial Intelligence (AI) in Radiation Dosing along with its subset deep learning technology provides distinct images for the modalities performed in various healthcare settings. The same provides low dosage radiations among the patient group. This technology pioneers the use of medical scans to derive appropriate radiation dosage, hence augmenting the field forward from using generic dose prescriptions. AI in Radiation dosing has its application in clinics, hospitals, diagnostic centers and research centers.
Without leveraging AI, radiation therapy can only be delivered uniformly which is not capable of reflecting differences in patient-specific factors such as individual tumor characteristics that may affect treatment success. This drawback is one of the primary factors driving the growth of the AI in Radiation dosing market. AI framework accounts for the variability that can reduce the treatment failure probability to less than 5 percent through personalized radiation doses. It helps physicians to develop data-driven, personalized dosage schedules that can maximize the probability of treatment success and mitigate radiation side effects for patients. This approach is anticipated to greatly benefit the field of radiotherapy with advanced dose optimization capabilities.
The development of AI in Radiation dosing is encouraging not only because it uses medical images to inform radiation dose prescriptions, but it also has the potential to strengthen holistic patient care. It provides the ability to individualize multiple cancer therapies and being viewed as a leap forward towards radiation precision medicine. For instance, France-based manufacturer of contrast agents, Guerbet LLC has entered a commercial partnership with Imalogix. The commercial partnership aims at identification of impact care delivery areas by combining Imalogix’s cloud-based human and machine-intelligence capabilities with Guerbet's capabilities in diagnostic and interventional imaging.
AI in Radiation dosing is resolving a significant issue for patients undergoing CT scans. Over the past several years, companies are making significant efforts to alleviate concerns about patient exposure to X-ray radiation associated with widely used CT scans. Machine learning and deep learning techniques have the ability to enable low radiation dose while producing higher quality scans compared to traditional reconstruction techniques.
In terms of revenue, the AI in Radiation dosing market stood at US$ 39.222 Mn in 2018, and is expected to grow at a CAGR of 30.2% during the forecast period of 2019 - 2027. The study analyzes the market in terms of revenue across all the major regions, which is further bifurcated into countries.
North America, AI in Radiation Dosing Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of AI in Radiation Dosing market, as well as provides comprehensive insights and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings, specification, pricing, and gross margin.
Some of the players operating in the AI in Radiation Dosing market are Bayer AG, Imalogix, Siemens Healthcare, Omega Medical Imaging, LLC, and icometrix amongst others.
AI in Radiation Dosing Market:
- By Type of Modalities
- Computed Tomography
- (CT) Scan
- MRI
- Mammography
- X-ray
- Ultrasound
- Others
- By End User
- Hospitals
- Diagnostic Center
- Medical Institutions
- Other Medical Groups
- By Geography
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Argentina
- Brazil
- Rest of Latin America
- North America
1.
Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Base
Year: 2018
1.2.2. Forecast
Years: 2019 – 2027
2.
Key Target Audiences
3.
Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4.
Recommendations and
Insights from AMI’s Perspective**
5.
Holistic Overview of AI in
Radiation Dosing Market
6.
Market Synopsis: AI in Radiation Dosing Market
7.
AI in Radiation Dosing
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
AI in Radiation Dosing Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: AI in Radiation Dosing Market
7.6. Porter’s Five Force Analysis
7.7. Analysis
of Technological Innovations in AI in Radiation Dosing Market
8.
Global AI in Radiation
Dosing Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
AI in Radiation Dosing Market Revenue (US$ Mn)
8.2. Global AI
in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
8.2.1. Ultrasound
8.2.1.1. Definition
8.2.1.2. Market
Penetration, 2018
8.2.1.3. Market
Estimation, 2018
8.2.1.4. Market
Forecast, 2019 – 2027
8.2.1.5. Compound
Annual Growth Rate (CAGR)
8.2.1.6. Regional
Bifurcation
8.2.1.6.1. North
America
8.2.1.6.1.1. Market
Estimation, 2018
8.2.1.6.1.2. Market
Forecast, 2019 – 2027
8.2.1.6.2. Europe
8.2.1.6.2.1. Market
Estimation, 2018
8.2.1.6.2.2. Market
Forecast, 2019 – 2027
8.2.1.6.3. Asia
Pacific
8.2.1.6.3.1. Market
Estimation, 2018
8.2.1.6.3.2. Market
Forecast, 2019 – 2027
8.2.1.6.4. Middle
East and Africa
8.2.1.6.4.1. Market
Estimation, 2018
8.2.1.6.4.2. Market
Forecast, 2019 – 2027
8.2.1.6.5. Latin
America
8.2.1.6.5.1. Market
Estimation, 2018
8.2.1.6.5.2. Market
Forecast, 2019 – 2027
8.2.2. X-Ray
8.2.2.1. Definition
8.2.2.2. Market
Penetration, 2018
8.2.2.3. Market
Estimation, 2018
8.2.2.4. Market
Forecast, 2019 – 2027
8.2.2.5. Compound
Annual Growth Rate (CAGR)
8.2.2.6. Regional
Bifurcation
8.2.2.6.1. North
America
8.2.2.6.1.1. Market
Estimation, 2018
8.2.2.6.1.2. Market
Forecast, 2019 – 2027
8.2.2.6.2. Europe
8.2.2.6.2.1. Market
Estimation, 2018
8.2.2.6.2.2. Market
Forecast, 2019 – 2027
8.2.2.6.3. Asia
Pacific
8.2.2.6.3.1. Market
Estimation, 2018
8.2.2.6.3.2. Market
Forecast, 2019 – 2027
8.2.2.6.4. Middle
East and Africa
8.2.2.6.4.1. Market
Estimation, 2018
8.2.2.6.4.2. Market
Forecast, 2019 – 2027
8.2.2.6.5. Latin
America
8.2.2.6.5.1. Market
Estimation, 2018
8.2.2.6.5.2. Market
Forecast, 2019 – 2027
8.2.3. MRI
8.2.3.1. Definition
8.2.3.2. Market
Penetration, 2018
8.2.3.3. Market
Estimation, 2018
8.2.3.4. Market
Forecast, 2019 – 2027
8.2.3.5. Compound
Annual Growth Rate (CAGR)
8.2.3.6. Regional
Bifurcation
8.2.3.6.1. North
America
8.2.3.6.1.1. Market
Estimation, 2018
8.2.3.6.1.2. Market
Forecast, 2019 – 2027
8.2.3.6.2. Europe
8.2.3.6.2.1. Market
Estimation, 2018
8.2.3.6.2.2. Market
Forecast, 2019 – 2027
8.2.3.6.3. Asia
Pacific
8.2.3.6.3.1. Market
Estimation, 2018
8.2.3.6.3.2. Market
Forecast, 2019 – 2027
8.2.3.6.4. Middle
East and Africa
8.2.3.6.4.1. Market
Estimation, 2018
8.2.3.6.4.2. Market
Forecast, 2019 – 2027
8.2.3.6.5. Latin
America
8.2.3.6.5.1. Market
Estimation, 2018
8.2.3.6.5.2. Market
Forecast, 2019 – 2027
8.2.4. CT Scan
8.2.4.1. Definition
8.2.4.2. Market
Penetration, 2018
8.2.4.3. Market
Estimation, 2018
8.2.4.4. Market
Forecast, 2019 – 2027
8.2.4.5. Compound
Annual Growth Rate (CAGR)
8.2.4.6. Regional
Bifurcation
8.2.4.6.1. North
America
8.2.4.6.1.1. Market
Estimation, 2018
8.2.4.6.1.2. Market
Forecast, 2019 – 2027
8.2.4.6.2. Europe
8.2.4.6.2.1. Market
Estimation, 2018
8.2.4.6.2.2. Market
Forecast, 2019 – 2027
8.2.4.6.3. Asia
Pacific
8.2.4.6.3.1. Market
Estimation, 2018
8.2.4.6.3.2. Market
Forecast, 2019 – 2027
8.2.4.6.4. Middle
East and Africa
8.2.4.6.4.1. Market
Estimation, 2018
8.2.4.6.4.2. Market
Forecast, 2019 – 2027
8.2.4.6.5. Latin
America
8.2.4.6.5.1. Market
Estimation, 2018
8.2.4.6.5.2. Market
Forecast, 2019 – 2027
8.2.5. Mammography
8.2.5.1. Definition
8.2.5.2. Market
Penetration, 2018
8.2.5.3. Market
Estimation, 2018
8.2.5.4. Market
Forecast, 2019 – 2027
8.2.5.5. Compound
Annual Growth Rate (CAGR)
8.2.5.6. Regional
Bifurcation
8.2.5.6.1. North
America
8.2.5.6.1.1. Market
Estimation, 2018
8.2.5.6.1.2. Market
Forecast, 2019 – 2027
8.2.5.6.2. Europe
8.2.5.6.2.1. Market
Estimation, 2018
8.2.5.6.2.2. Market
Forecast, 2019 – 2027
8.2.5.6.3. Asia
Pacific
8.2.5.6.3.1. Market
Estimation, 2018
8.2.5.6.3.2. Market
Forecast, 2019 – 2027
8.2.5.6.4. Middle
East and Africa
8.2.5.6.4.1. Market
Estimation, 2018
8.2.5.6.4.2. Market
Forecast, 2019 – 2027
8.2.5.6.5. Latin
America
8.2.5.6.5.1. Market
Estimation, 2018
8.2.5.6.5.2. Market
Forecast, 2019 – 2027
8.2.6. Others
8.2.6.1. Definition
8.2.6.2. Market
Penetration, 2018
8.2.6.3. Market
Estimation, 2018
8.2.6.4. Market
Forecast, 2019 – 2027
8.2.6.5. Compound
Annual Growth Rate (CAGR)
8.2.6.6. Regional
Bifurcation
8.2.6.6.1. North
America
8.2.6.6.1.1. Market
Estimation, 2018
8.2.6.6.1.2. Market
Forecast, 2019 – 2027
8.2.6.6.2. Europe
8.2.6.6.2.1. Market
Estimation, 2018
8.2.6.6.2.2. Market
Forecast, 2019 – 2027
8.2.6.6.3. Asia
Pacific
8.2.6.6.3.1. Market
Estimation, 2018
8.2.6.6.3.2. Market
Forecast, 2019 – 2027
8.2.6.6.4. Middle
East and Africa
8.2.6.6.4.1. Market
Estimation, 2018
8.2.6.6.4.2. Market
Forecast, 2019 – 2027
8.2.6.6.5. Latin
America
8.2.6.6.5.1. Market
Estimation, 2018
8.2.6.6.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Modalities
9.
Global AI in Radiation
Dosing Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global AI
in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
9.2.1. Hospitals
9.2.1.1. Definition
9.2.1.2. Market
Penetration, 2018
9.2.1.3. Market
Estimation, 2018
9.2.1.4. Market
Forecast, 2019 – 2027
9.2.1.5. Compound
Annual Growth Rate (CAGR)
9.2.1.6. Regional
Bifurcation
9.2.1.6.1. North
America
9.2.1.6.1.1. Market
Estimation, 2018
9.2.1.6.1.2. Market
Forecast, 2019 – 2027
9.2.1.6.2. Europe
9.2.1.6.2.1. Market
Estimation, 2018
9.2.1.6.2.2. Market
Forecast, 2019 – 2027
9.2.1.6.3. Asia
Pacific
9.2.1.6.3.1. Market
Estimation, 2018
9.2.1.6.3.2. Market
Forecast, 2019 – 2027
9.2.1.6.4. Middle
East and Africa
9.2.1.6.4.1. Market
Estimation, 2018
9.2.1.6.4.2. Market
Forecast, 2019 – 2027
9.2.1.6.5. Latin
America
9.2.1.6.5.1. Market
Estimation, 2018
9.2.1.6.5.2. Market
Forecast, 2019 – 2027
9.2.2. Medical
Institutions
9.2.2.1. Definition
9.2.2.2. Market
Penetration, 2018
9.2.2.3. Market
Estimation, 2018
9.2.2.4. Market
Forecast, 2019 – 2027
9.2.2.5. Compound
Annual Growth Rate (CAGR)
9.2.2.6. Regional
Bifurcation
9.2.2.6.1. North
America
9.2.2.6.1.1. Market
Estimation, 2018
9.2.2.6.1.2. Market
Forecast, 2019 – 2027
9.2.2.6.2. Europe
9.2.2.6.2.1. Market
Estimation, 2018
9.2.2.6.2.2. Market
Forecast, 2019 – 2027
9.2.2.6.3. Asia
Pacific
9.2.2.6.3.1. Market
Estimation, 2018
9.2.2.6.3.2. Market
Forecast, 2019 – 2027
9.2.2.6.4. Middle
East and Africa
9.2.2.6.4.1. Market
Estimation, 2018
9.2.2.6.4.2. Market
Forecast, 2019 – 2027
9.2.2.6.5. Latin
America
9.2.2.6.5.1. Market
Estimation, 2018
9.2.2.6.5.2. Market
Forecast, 2019 – 2027
9.2.3. Diagnostics
Centers
9.2.3.1. Definition
9.2.3.2. Market
Penetration, 2018
9.2.3.3. Market
Estimation, 2018
9.2.3.4. Market
Forecast, 2019 – 2027
9.2.3.5. Compound
Annual Growth Rate (CAGR)
9.2.3.6. Regional
Bifurcation
9.2.3.6.1. North
America
9.2.3.6.1.1. Market
Estimation, 2018
9.2.3.6.1.2. Market
Forecast, 2019 – 2027
9.2.3.6.2. Europe
9.2.3.6.2.1. Market
Estimation, 2018
9.2.3.6.2.2. Market
Forecast, 2019 – 2027
9.2.3.6.3. Asia
Pacific
9.2.3.6.3.1. Market
Estimation, 2018
9.2.3.6.3.2. Market
Forecast, 2019 – 2027
9.2.3.6.4. Middle
East and Africa
9.2.3.6.4.1. Market
Estimation, 2018
9.2.3.6.4.2. Market
Forecast, 2019 – 2027
9.2.3.6.5. Latin
America
9.2.3.6.5.1. Market
Estimation, 2018
9.2.3.6.5.2. Market
Forecast, 2019 – 2027
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market
Penetration, 2018
9.2.4.3. Market
Estimation, 2018
9.2.4.4. Market
Forecast, 2019 – 2027
9.2.4.5. Compound
Annual Growth Rate (CAGR)
9.2.4.6. Regional
Bifurcation
9.2.4.6.1. North
America
9.2.4.6.1.1. Market
Estimation, 2018
9.2.4.6.1.2. Market
Forecast, 2019 – 2027
9.2.4.6.2. Europe
9.2.4.6.2.1. Market
Estimation, 2018
9.2.4.6.2.2. Market
Forecast, 2019 – 2027
9.2.4.6.3. Asia
Pacific
9.2.4.6.3.1. Market
Estimation, 2018
9.2.4.6.3.2. Market
Forecast, 2019 – 2027
9.2.4.6.4. Middle
East and Africa
9.2.4.6.4.1. Market
Estimation, 2018
9.2.4.6.4.2. Market
Forecast, 2019 – 2027
9.2.4.6.5. Latin
America
9.2.4.6.5.1. Market
Estimation, 2018
9.2.4.6.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By End
User
10.
North America AI in
Radiation Dosing Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North
America AI in Radiation Dosing Market Revenue (US$ Mn)
10.2. North
America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
10.2.1. Ultrasound
10.2.2. X-Ray
10.2.3. MRI
10.2.4. CT Scan
10.2.5. Mammography
10.2.6. Others
10.3. North
America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
10.3.1. Hospitals
10.3.2. Medical
Institutions
10.3.3. Diagnostics
Centers
10.3.4. Others
10.4. North
America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
10.4.1.1.1. Ultrasound
10.4.1.1.2. X-Ray
10.4.1.1.3. MRI
10.4.1.1.4. CT
Scan
10.4.1.1.5. Mammography
10.4.1.1.6. Others
10.4.1.2. U.S
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
10.4.1.2.1. Hospitals
10.4.1.2.2. Medical
Institutions
10.4.1.2.3. Diagnostics
Centers
10.4.1.2.4. Others
10.4.2. Canada
10.4.2.1. Canada
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
10.4.2.1.1. Ultrasound
10.4.2.1.2. X-Ray
10.4.2.1.3. MRI
10.4.2.1.4. CT
Scan
10.4.2.1.5. Mammography
10.4.2.1.6. Others
10.4.2.2. Canada
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
10.4.2.2.1. Hospitals
10.4.2.2.2. Medical
Institutions
10.4.2.2.3. Diagnostics
Centers
10.4.2.2.4. Others
10.4.3. Mexico
10.4.3.1. Mexico
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
10.4.3.1.1. Ultrasound
10.4.3.1.2. X-Ray
10.4.3.1.3. MRI
10.4.3.1.4. CT
Scan
10.4.3.1.5. Mammography
10.4.3.1.6. Others
10.4.3.2. Mexico
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
10.4.3.2.1. Hospitals
10.4.3.2.2. Medical
Institutions
10.4.3.2.3. Diagnostics
Centers
10.4.3.2.4. Others
10.4.4. Rest of
North America
10.4.4.1. Rest
of North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By Modalities
10.4.4.1.1. Ultrasound
10.4.4.1.2. X-Ray
10.4.4.1.3. MRI
10.4.4.1.4. CT
Scan
10.4.4.1.5. Mammography
10.4.4.1.6. Others
10.4.4.2. Rest
of North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By End User
10.4.4.2.1. Hospitals
10.4.4.2.2. Medical
Institutions
10.4.4.2.3. Diagnostics
Centers
10.4.4.2.4. Others
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Modalities
10.5.3. By End
User
11.
Europe AI in Radiation
Dosing Market Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe
AI in Radiation Dosing Market Revenue (US$ Mn)
11.2. Europe AI
in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
11.2.1. Ultrasound
11.2.2. X-Ray
11.2.3. MRI
11.2.4. CT Scan
11.2.5. Mammography
11.2.6. Others
11.3. Europe AI
in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.3.1. Hospitals
11.3.2. Medical
Institutions
11.3.3. Diagnostics
Centers
11.3.4. Others
11.4. Europe AI
in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1. France
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
11.4.1.1.1. Ultrasound
11.4.1.1.2. X-Ray
11.4.1.1.3. MRI
11.4.1.1.4. CT
Scan
11.4.1.1.5. Mammography
11.4.1.1.6. Others
11.4.1.2. France
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.4.1.2.1. Hospitals
11.4.1.2.2. Medical
Institutions
11.4.1.2.3. Diagnostics
Centers
11.4.1.2.4. Others
11.4.2. The UK
11.4.2.1. The
UK AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
11.4.2.1.1. Ultrasound
11.4.2.1.2. X-Ray
11.4.2.1.3. MRI
11.4.2.1.4. CT
Scan
11.4.2.1.5. Mammography
11.4.2.1.6. Others
11.4.2.2. The
UK AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.4.2.2.1. Hospitals
11.4.2.2.2. Medical
Institutions
11.4.2.2.3. Diagnostics
Centers
11.4.2.2.4. Others
11.4.3. Spain
11.4.3.1. Spain
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
11.4.3.1.1. Ultrasound
11.4.3.1.2. X-Ray
11.4.3.1.3. MRI
11.4.3.1.4. CT
Scan
11.4.3.1.5. Mammography
11.4.3.1.6. Others
11.4.3.2. Spain
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.4.3.2.1. Hospitals
11.4.3.2.2. Medical
Institutions
11.4.3.2.3. Diagnostics
Centers
11.4.3.2.4. Others
11.4.4. Germany
11.4.4.1. Germany
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
11.4.4.1.1. Ultrasound
11.4.4.1.2. X-Ray
11.4.4.1.3. MRI
11.4.4.1.4. CT
Scan
11.4.4.1.5. Mammography
11.4.4.1.6. Others
11.4.4.2. Germany
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.4.4.2.1. Hospitals
11.4.4.2.2. Medical
Institutions
11.4.4.2.3. Diagnostics
Centers
11.4.4.2.4. Others
11.4.5. Italy
11.4.5.1. Italy
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
11.4.5.1.1. Ultrasound
11.4.5.1.2. X-Ray
11.4.5.1.3. MRI
11.4.5.1.4. CT
Scan
11.4.5.1.5. Mammography
11.4.5.1.6. Others
11.4.5.2. Italy
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.4.5.2.1. Hospitals
11.4.5.2.2. Medical
Institutions
11.4.5.2.3. Diagnostics
Centers
11.4.5.2.4. Others
11.4.6. Nordic
Countries
11.4.6.1. Nordic
Countries AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
11.4.6.1.1. Ultrasound
11.4.6.1.2. X-Ray
11.4.6.1.3. MRI
11.4.6.1.4. CT
Scan
11.4.6.1.5. Mammography
11.4.6.1.6. Others
11.4.6.2. Nordic
Countries AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.6.2.1. Hospitals
11.4.6.2.2. Medical
Institutions
11.4.6.2.3. Diagnostics
Centers
11.4.6.2.4. Others
11.4.6.3. Nordic
Countries AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux
Union AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
11.4.7.1.1. Ultrasound
11.4.7.1.2. X-Ray
11.4.7.1.3. MRI
11.4.7.1.4. CT
Scan
11.4.7.1.5. Mammography
11.4.7.1.6. Others
11.4.7.2. Benelux
Union AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
11.4.7.2.1. Hospitals
11.4.7.2.2. Medical
Institutions
11.4.7.2.3. Diagnostics
Centers
11.4.7.2.4. Others
11.4.7.3. Benelux
Union AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The
Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest
of Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
11.4.8.1.1. Ultrasound
11.4.8.1.2. X-Ray
11.4.8.1.3. MRI
11.4.8.1.4. CT
Scan
11.4.8.1.5. Mammography
11.4.8.1.6. Others
11.4.8.2. Rest
of Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
11.4.8.2.1. Hospitals
11.4.8.2.2. Medical
Institutions
11.4.8.2.3. Diagnostics
Centers
11.4.8.2.4. Others
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Modalities
11.5.3. By End
User
12.
Asia Pacific AI in
Radiation Dosing Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia
Pacific AI in Radiation Dosing Market Revenue (US$ Mn)
12.2. Asia
Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
12.2.1. Ultrasound
12.2.2. X-Ray
12.2.3. MRI
12.2.4. CT Scan
12.2.5. Mammography
12.2.6. Others
12.3. Asia
Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
12.3.1. Hospitals
12.3.2. Medical
Institutions
12.3.3. Diagnostics
Centers
12.3.4. Others
12.4. Asia
Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Country
12.4.1. China
12.4.1.1. China
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
12.4.1.1.1. Ultrasound
12.4.1.1.2. X-Ray
12.4.1.1.3. MRI
12.4.1.1.4. CT
Scan
12.4.1.1.5. Mammography
12.4.1.1.6. Others
12.4.1.2. China
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
12.4.1.2.1. Hospitals
12.4.1.2.2. Medical
Institutions
12.4.1.2.3. Diagnostics
Centers
12.4.1.2.4. Others
12.4.2. Japan
12.4.2.1. Japan
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
12.4.2.1.1. Ultrasound
12.4.2.1.2. X-Ray
12.4.2.1.3. MRI
12.4.2.1.4. CT
Scan
12.4.2.1.5. Mammography
12.4.2.1.6. Others
12.4.2.2. Japan
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
12.4.2.2.1. Hospitals
12.4.2.2.2. Medical
Institutions
12.4.2.2.3. Diagnostics
Centers
12.4.2.2.4. Others
12.4.3. India
12.4.3.1. India
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
12.4.3.1.1. Ultrasound
12.4.3.1.2. X-Ray
12.4.3.1.3. MRI
12.4.3.1.4. CT
Scan
12.4.3.1.5. Mammography
12.4.3.1.6. Others
12.4.3.2. India
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
12.4.3.2.1. Hospitals
12.4.3.2.2. Medical
Institutions
12.4.3.2.3. Diagnostics
Centers
12.4.3.2.4. Others
12.4.4. New
Zealand
12.4.4.1. New
Zealand AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
12.4.4.1.1. Ultrasound
12.4.4.1.2. X-Ray
12.4.4.1.3. MRI
12.4.4.1.4. CT
Scan
12.4.4.1.5. Mammography
12.4.4.1.6. Others
12.4.4.2. New
Zealand AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
12.4.4.2.1. Hospitals
12.4.4.2.2. Medical
Institutions
12.4.4.2.3. Diagnostics
Centers
12.4.4.2.4. Others
12.4.5. Australia
12.4.5.1. Australia
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
12.4.5.1.1. Ultrasound
12.4.5.1.2. X-Ray
12.4.5.1.3. MRI
12.4.5.1.4. CT
Scan
12.4.5.1.5. Mammography
12.4.5.1.6. Others
12.4.5.2. Australia
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
12.4.5.2.1. Hospitals
12.4.5.2.2. Medical
Institutions
12.4.5.2.3. Diagnostics
Centers
12.4.5.2.4. Others
12.4.6. South
Korea
12.4.6.1. South
Korea AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
12.4.6.1.1. Ultrasound
12.4.6.1.2. X-Ray
12.4.6.1.3. MRI
12.4.6.1.4. CT
Scan
12.4.6.1.5. Mammography
12.4.6.1.6. Others
12.4.6.2. South
Korea AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
12.4.6.2.1. Hospitals
12.4.6.2.2. Medical
Institutions
12.4.6.2.3. Diagnostics
Centers
12.4.6.2.4. Others
12.4.7. Southeast
Asia
12.4.7.1. Southeast
Asia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
12.4.7.1.1. Ultrasound
12.4.7.1.2. X-Ray
12.4.7.1.3. MRI
12.4.7.1.4. CT
Scan
12.4.7.1.5. Mammography
12.4.7.1.6. Others
12.4.7.2. Southeast
Asia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
12.4.7.2.1. Hospitals
12.4.7.2.2. Medical
Institutions
12.4.7.2.3. Diagnostics
Centers
12.4.7.2.4. Others
12.4.7.3. Southeast
Asia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest
of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest
of Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By Modalities
12.4.8.1.1. Ultrasound
12.4.8.1.2. X-Ray
12.4.8.1.3. MRI
12.4.8.1.4. CT
Scan
12.4.8.1.5. Mammography
12.4.8.1.6. Others
12.4.8.2. Rest
of Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By End User
12.4.8.2.1. Hospitals
12.4.8.2.2. Medical
Institutions
12.4.8.2.3. Diagnostics
Centers
12.4.8.2.4. Others
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Modalities
12.5.3. By End
User
13.
Middle East and Africa AI
in Radiation Dosing Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle
East and Africa AI in Radiation Dosing Market Revenue (US$ Mn)
13.2. Middle
East and Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By Modalities
13.2.1. Ultrasound
13.2.2. X-Ray
13.2.3. MRI
13.2.4. CT Scan
13.2.5. Mammography
13.2.6. Others
13.3. Middle
East and Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By End User
13.3.1. Hospitals
13.3.2. Medical
Institutions
13.3.3. Diagnostics
Centers
13.3.4. Others
13.4. Middle
East and Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi
Arabia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
13.4.1.1.1. Ultrasound
13.4.1.1.2. X-Ray
13.4.1.1.3. MRI
13.4.1.1.4. CT
Scan
13.4.1.1.5. Mammography
13.4.1.1.6. Others
13.4.1.2. Saudi
Arabia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
13.4.1.2.1. Hospitals
13.4.1.2.2. Medical
Institutions
13.4.1.2.3. Diagnostics
Centers
13.4.1.2.4. Others
13.4.2. UAE
13.4.2.1. UAE
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
13.4.2.1.1. Ultrasound
13.4.2.1.2. X-Ray
13.4.2.1.3. MRI
13.4.2.1.4. CT
Scan
13.4.2.1.5. Mammography
13.4.2.1.6. Others
13.4.2.2. UAE
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
13.4.2.2.1. Hospitals
13.4.2.2.2. Medical
Institutions
13.4.2.2.3. Diagnostics
Centers
13.4.2.2.4. Others
13.4.3. Egypt
13.4.3.1. Egypt
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
13.4.3.1.1. Ultrasound
13.4.3.1.2. X-Ray
13.4.3.1.3. MRI
13.4.3.1.4. CT
Scan
13.4.3.1.5. Mammography
13.4.3.1.6. Others
13.4.3.2. Egypt
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
13.4.3.2.1. Hospitals
13.4.3.2.2. Medical
Institutions
13.4.3.2.3. Diagnostics
Centers
13.4.3.2.4. Others
13.4.4. Kuwait
13.4.4.1. Kuwait
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
13.4.4.1.1. Ultrasound
13.4.4.1.2. X-Ray
13.4.4.1.3. MRI
13.4.4.1.4. CT
Scan
13.4.4.1.5. Mammography
13.4.4.1.6. Others
13.4.4.2. Kuwait
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
13.4.4.2.1. Hospitals
13.4.4.2.2. Medical
Institutions
13.4.4.2.3. Diagnostics
Centers
13.4.4.2.4. Others
13.4.5. South
Africa
13.4.5.1. South
Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
13.4.5.1.1. Ultrasound
13.4.5.1.2. X-Ray
13.4.5.1.3. MRI
13.4.5.1.4. CT
Scan
13.4.5.1.5. Mammography
13.4.5.1.6. Others
13.4.5.2. South
Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
13.4.5.2.1. Hospitals
13.4.5.2.2. Medical
Institutions
13.4.5.2.3. Diagnostics
Centers
13.4.5.2.4. Others
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest
of Middle East & Africa AI in Radiation Dosing Market Revenue (US$ Mn) and
Forecasts, By Modalities
13.4.6.1.1. Ultrasound
13.4.6.1.2. X-Ray
13.4.6.1.3. MRI
13.4.6.1.4. CT
Scan
13.4.6.1.5. Mammography
13.4.6.1.6. Others
13.4.6.2. Rest
of Middle East & Africa AI in Radiation Dosing Market Revenue (US$ Mn) and
Forecasts, By End User
13.4.6.2.1. Hospitals
13.4.6.2.2. Medical
Institutions
13.4.6.2.3. Diagnostics
Centers
13.4.6.2.4. Others
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Modalities
13.5.3. By End
User
14.
Latin America AI in
Radiation Dosing Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin
America AI in Radiation Dosing Market Revenue (US$ Mn)
14.2. Latin
America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Modalities
14.2.1. Ultrasound
14.2.2. X-Ray
14.2.3. MRI
14.2.4. CT Scan
14.2.5. Mammography
14.2.6. Others
14.3. Latin
America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End
User
14.3.1. Hospitals
14.3.2. Medical
Institutions
14.3.3. Diagnostics
Centers
14.3.4. Others
14.4. Latin
America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By
Country
14.4.1. Brazil
14.4.1.1. Brazil
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
14.4.1.1.1. Ultrasound
14.4.1.1.2. X-Ray
14.4.1.1.3. MRI
14.4.1.1.4. CT
Scan
14.4.1.1.5. Mammography
14.4.1.1.6. Others
14.4.1.2. Brazil
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
14.4.1.2.1. Hospitals
14.4.1.2.2. Medical
Institutions
14.4.1.2.3. Diagnostics
Centers
14.4.1.2.4. Others
14.4.2. Argentina
14.4.2.1. Argentina
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities
14.4.2.1.1. Ultrasound
14.4.2.1.2. X-Ray
14.4.2.1.3. MRI
14.4.2.1.4. CT
Scan
14.4.2.1.5. Mammography
14.4.2.1.6. Others
14.4.2.2. Argentina
AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User
14.4.2.2.1. Hospitals
14.4.2.2.2. Medical
Institutions
14.4.2.2.3. Diagnostics
Centers
14.4.2.2.4. Others
14.4.3. Rest of
Latin America
14.4.3.1. Rest
of Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By Modalities
14.4.3.1.1. Ultrasound
14.4.3.1.2. X-Ray
14.4.3.1.3. MRI
14.4.3.1.4. CT
Scan
14.4.3.1.5. Mammography
14.4.3.1.6. Others
14.4.3.2. Rest
of Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts,
By End User
14.4.3.2.1. Hospitals
14.4.3.2.2. Medical
Institutions
14.4.3.2.3. Diagnostics
Centers
14.4.3.2.4. Others
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By
Modalities
14.5.3. By End
User
15.
Competitive Benchmarking
15.1. Market
Share Analysis, 2018
15.2. Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16.
Player Profiles
16.1. Bayer
HealthCare LLC.
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Imalogix
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Koninklijke
Philips N.V.
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. Siemens
Healthcare Private Limited
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. Other
Market Players
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
17.
Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.